RIVANOVA

WHO-GMP · ISO 9001:2015 certified manufacturing · Serving 25+ countries

About RIVANOVA

Medicine made with
uncompromising intent

We exist to make dependable, affordable, world-class medicine — engineered by scientists, verified by data, and trusted by clinicians across four continents.

Our company

We started with an
uncomfortable question

In 2005, RIVANOVA Healthcare Pvt Limited began as a single oral-solids block on the outskirts of Ahmedabad with eighteen employees and one conviction: that affordable medicine should not be held to a lower standard than expensive medicine. The pharmaceutical industry had long treated the two as a trade-off. We did not accept it then, and the last twenty years have been an argument against it.

That argument is made in specifications, not slogans. It is made by an independent quality assurance function that reports outside production and has the authority to reject a batch — an authority it has used. It is made by developing our own formulations rather than licensing someone else's, so that we can explain every excipient choice and defend every specification limit in front of any regulator.

Today we operate four dedicated production blocks across 1,40,000 sq. ft. of controlled space, a 12,000 sq. ft. research centre staffed by 42 scientists, and a distribution network that reaches 1,200+ partners in India and 25+ countries abroad. The scale has changed considerably. The standard has not moved at all.

0 Years of operation
0 People employed
0 Sq. ft. controlled area
0 Batch conformance

A batch that meets specification is not an achievement. It is the minimum we owe the person who will swallow it.

Managing Director

RIVANOVA Healthcare Pvt Limited

Mission & vision

What we are for

Our Mission

To manufacture and market pharmaceutical formulations of uncompromising quality at prices that do not exclude the people who need them — supported by science we generate ourselves and evidence we can produce on demand.

  • Hold every batch to pharmacopoeial specification, without exception or negotiation
  • Develop in-house, so every formulation decision is ours to explain and defend
  • Keep supply predictable, because an unavailable medicine has failed its patient

Our Vision

To be the manufacturing partner that healthcare institutions choose when the consequence of failure is highest — recognised across emerging and regulated markets alike for quality systems that hold up to unannounced scrutiny.

  • Expand into regulated markets without diluting a single control
  • Stay audit-ready every day of the year, not only when an inspection is scheduled
  • Build a workplace where raising a quality concern is the safest thing an employee can do

Core values

Six commitments we test ourselves against

Values are only real if they cost something when honoured. Each of these has.

Integrity before volume

If a batch is doubtful, it does not ship. Commercial pressure is not an input to that decision, and never has been.

Evidence over assertion

Every claim we make about a product is traceable to a chromatogram, a dissolution profile or a stability chamber reading.

The patient is the point

Palatability, pack legibility and dosing convenience are quality attributes. A course not completed is a treatment not delivered.

Partners, not accounts

Territories are protected, terms are written down, and near-expiry policy is honoured without argument.

Manufacture responsibly

Zero-liquid-discharge effluent treatment, solvent recovery and 42% of site energy from rooftop solar.

Speak plainly

To regulators, to partners, to our own people. Ambiguity in this industry has a body count.

Our journey

Twenty years, milestone by milestone

  1. 2005

    Incorporation and first block

    RIVANOVA Healthcare Pvt Limited is incorporated with a single oral-solids manufacturing block, eighteen employees and distribution across four districts of western India.

  2. 2009

    WHO-GMP certification

    First WHO-GMP certificate granted after a full facility audit, unlocking government institutional tenders and the first export consignments into South-East Asia.

  3. 2012

    Oral liquids and topicals

    Dedicated blocks commissioned for syrups, suspensions, creams and ointments, taking the portfolio past 200 SKUs across four dosage forms.

  4. 2014

    Research centre commissioned

    A 12,000 sq. ft. formulation and analytical development centre opens, ending all reliance on third-party development and bringing method validation in-house.

  5. 2016

    ISO 9001 and ISO 14001

    Quality and environmental management systems certified, alongside commissioning of the zero-liquid-discharge effluent treatment plant.

  6. 2018

    Sterile injectable suite

    Grade A/B aseptic block validated with online particle monitoring and 100% visual inspection, adding dry-powder and liquid vials to the portfolio.

  7. 2021

    Nutraceutical division

    FSSAI-licensed clinical nutrition and nutraceutical lines added, with dehumidified blending suites for protein and vitamin formulations.

  8. 2023

    Digital batch records

    Electronic batch record system deployed across all blocks under 21 CFR Part 11 controls, with audit trails reviewed by QA prior to release.

  9. 2026

    Twenty-five markets, 480+ SKUs

    Live registrations across 25+ countries, a fourth compression suite commissioned, and a distributor network exceeding 1,200 partners.

Want to see the systems behind the story?

Our facilities are audit-ready year-round. Site master files, validation master plans and quality manuals are available for review on request.